Search CROs

Listed on cro

Global CRO with 25+ years of experience and world-renowned renal expertise, offering end-to-end clinical trial services across renal, oncology, cardiovascular, and early-phase research with operations spanning 70+ countries.

Listed on cro

Clinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale.

Listed on cro

Global, full-service CRO specializing in oncology and rare disease clinical solutions from proof-of-concept through commercialization.

Listed on cro

Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

Listed on cro

World's largest independent, community-based clinical trial site network offering decentralized and mobile research services across diverse patient populations globally.

Listed on cro

Global clinical trial laboratory services with central labs across six continents, specializing in bioanalytical, immunogenicity, genomics, and vaccine testing with 30+ years of industry expertise.

Listed on cro

Beaufort is a MedTech-specialized CRO offering clinical operations, regulatory strategy, and submission support tailored to device and diagnostic innovations across all therapeutic areas.

Listed on cro

Voiant is the industry-leading imaging CRO for clinical trial imaging and endpoint adjudication, leveraging 30+ years of clinical expertise and AI-powered technology to deliver high-quality endpoint data across Phase I–IV global trials.

Listed on cro

Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

Listed on cro

Full-service CRO delivering clinical trial management across early to late phases, with specialist expertise in rare diseases and oncology.

Listed on cro

Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.

Listed on cro

Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.

Listed on cro

YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.

Listed on cro

Full-service CRO with 30+ years of experience offering Phase I–III clinical trials, biostatistics, medical writing, and health economics services across 20+ countries with strong academic affiliations.

Listed on cro

Global CRO offering full-service and flexible outsourcing across early clinical, bioanalytical, cardiac safety, specialty laboratory, and clinical operations; serves pharma, biotech, and medical device sponsors from molecule to commercialization.

Listed on cro

ethica CRO is the first contract research organization in the world to achieve HRPP accreditation from three distinct accrediting bodies, specializing in medical aesthetics, dermatology, and clinical trial management with a focus on ethical excellence and participant safety.

Listed on cro

Quanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.

Listed on cro

Indero is a dual-focus CRO specializing in dermatology and rheumatology clinical trials, offering end-to-end services from early to late phase with global capabilities across North America, Europe, Latin America, and Asia-Pacific.

Listed on cro

Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.

Listed on cro

PharPoint is a US-based CRO specializing in Phase I–IV clinical trials with rapid biometrics timelines, delivering database locks within 5 days of last patient visit and topline results in 2 business days.